Holdings (as at 2025-04-01)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 99.88%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2025-04-01)
Security Name % of Net Assets
Corcept Therapeutics Inc. 6.40%
BeiGene, Ltd. (ADR) 5.33%
Intra-Cellular Therapies, Inc. 4.83%
Gilead Sciences, Inc. 4.30%
Vertex Pharmaceuticals Incorporated 4.11%
Halozyme Therapeutics, Inc. 4.07%
Amgen Inc. 4.06%
Alkermes Plc 4.02%
Alnylam Pharmaceuticals, Inc. 3.73%
Exelixis, Inc. 3.51%
BioMarin Pharmaceutical Inc. 3.50%
Mettler-Toledo International Inc. 3.32%
ACADIA Pharmaceuticals Inc. 3.28%
Waters Corporation 3.25%
Biogen Inc. 3.08%
Regeneron Pharmaceuticals, Inc. 3.07%
argenx SE (ADR) 3.00%
Incyte Corporation 3.00%
Genmab A/S (ADR) 2.92%
United Therapeutics Corporation 2.92%
Repligen Corporation 2.88%
Natera, Inc. 2.79%
Exact Sciences Corporation 2.67%
Neurocrine Biosciences, Inc. 2.64%
BioNTech SE (ADR) 2.55%
Veracyte, Inc. 2.47%
Bruker Corporation 2.31%
Moderna, Inc. 2.23%
Illumina, Inc. 1.99%
Sarepta Therapeutics, Inc. 1.72%
Dreyfus Government Cash Management (Institutional Shares) 0.11%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.